FDA cites examples to show US medtech regulations are stricter than EU's
This article was originally published in Clinica
The US Food and Drug Administration has provided examples in support of its belief that medical devices in the US are subject to stricter regulations before they are allowed on the market compared with those in the EU.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.